A tale of two cells: ViroCell and AvenCell join forces on viral vector production for CAR-T therapies Florence BuchananJuly 30, 2025
ViroCell Biologics Appoint Meredith Brown as Senior Director, & Elaine Rihn as Director of Business Development Florence BuchananDecember 17, 2024
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Florence BuchananJuly 25, 2024
ViroCell Biologics Forms Master Services Agreement with Top NCI-Designated Cancer Center Florence BuchananJuly 23, 2024
ViroCell Biologics signs Master Services Agreement with NCI-designated cancer centre Florence BuchananJuly 23, 2024
ViroCell gets UK green light to produce viral vectors at children’s hospital facility Florence BuchananNovember 2, 2023
We have previously reported on the UK losing ground globally in conducting clinical trials, which are needed to test new medicines on patients. Florence BuchananNovember 1, 2023
ViroCell to operate from a London facility to manufacture viral vectors for clinical trials Florence BuchananNovember 1, 2023
Great Ormond Street Hospital secures UK MHRA permission to manufacture viral vectors Florence BuchananNovember 1, 2023
ViroCell, Great Ormond Street Hospital partner to unlock clinical trial backlog Florence BuchananNovember 1, 2023
